Suppr超能文献

8例波兰遗传性凝血因子XIII缺乏症患者的表型-基因型相关性:鉴定出三种新突变

Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.

作者信息

Ivaskevicius V, Windyga J, Baran B, Schroeder V, Junen J, Bykowska K, Seifried E, Kohler H P, Oldenburg J

机构信息

Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, 53127 Bonn, Germany.

出版信息

Haemophilia. 2007 Sep;13(5):649-57. doi: 10.1111/j.1365-2516.2007.01517.x.

Abstract

Inherited factor XIII (FXIII) deficiency is known as one of the most rare blood coagulation disorder in humans. In the present study, phenotype and genotype of eight FXIII deficient Polish patients from five unrelated families were compared. The patients presented with a severe phenotype demonstrated by a high incidence of intracerebral haemorrhages (seven of eight patients), haemarthrosis (six patients) and bleeding due to trauma (five patients). Introduction of regular substitution with FXIII concentrate prevented spontaneous bleeding in seven patients. In all patients, mutations within the F13A gene have been identified revealing four missense mutations (Arg77Cys, Arg260Cys, Ala378Pro, Gly420Ser), one nonsense mutation (Arg661X), one splice site mutation (IVS5-1 G>A) and one small deletion (c.499-512del). One homozygous large deletion involving exon 15 was detected by failure of PCR product. The corresponding mutations resulted in severely reduced FXIII activity and FXIII A-subunit antigen concentration, while FXIII B-subunit antigen remained normal or mildly decreased. Structural analysis demonstrated that the novel Ala378Pro mutation may cause a disruption of the FXIII catalytic triad leading to a non-functional protein which presumably undergoes premature degradation. In conclusion, the severe phenotype with high incidence of intracranial bleeding and haemarthrosis was in accordance with laboratory findings on FXIII and with severe molecular defects of the F13A gene.

摘要

遗传性因子 XIII(FXIII)缺乏症是已知人类中最罕见的凝血障碍之一。在本研究中,对来自五个无亲缘关系家庭的八名波兰 FXIII 缺乏症患者的表型和基因型进行了比较。这些患者表现出严重的表型,表现为脑出血发生率高(八名患者中有七名)、关节积血(六名患者)和创伤后出血(五名患者)。定期用 FXIII 浓缩物替代可防止七名患者出现自发性出血。在所有患者中,均已鉴定出 F13A 基因内的突变,发现了四个错义突变(Arg77Cys、Arg260Cys、Ala378Pro、Gly420Ser)、一个无义突变(Arg661X)、一个剪接位点突变(IVS5-1 G>A)和一个小缺失(c.499-512del)。通过 PCR 产物未出现检测到一个涉及外显子 15 的纯合大缺失。相应的突变导致 FXIII 活性和 FXIII A 亚基抗原浓度严重降低,而 FXIII B 亚基抗原保持正常或轻度降低。结构分析表明,新的 Ala378Pro 突变可能导致 FXIII 催化三联体的破坏,导致产生无功能的蛋白质,推测该蛋白质会过早降解。总之,颅内出血和关节积血发生率高的严重表型与 FXIII 的实验室检查结果以及 F13A 基因的严重分子缺陷一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验